Free Trial

Ondine Biomedical (LON:OBI) Reaches New 12-Month High - Still a Buy?

Ondine Biomedical logo with Medical background

Ondine Biomedical Inc. (LON:OBI - Get Free Report) reached a new 52-week high during trading on Monday . The company traded as high as C$15.00 and last traded at C$15.00, with a volume of 620442 shares trading hands. The stock had previously closed at C$14.00.

Ondine Biomedical Price Performance

The company has a quick ratio of 8.26, a current ratio of 1.36 and a debt-to-equity ratio of 25.95. The business's 50-day moving average is C$10.85 and its two-hundred day moving average is C$10.52. The company has a market capitalization of C$104.26 million, a P/E ratio of -4.37 and a beta of 0.10.

About Ondine Biomedical

(Get Free Report)

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens. Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Ondine Biomedical Right Now?

Before you consider Ondine Biomedical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ondine Biomedical wasn't on the list.

While Ondine Biomedical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines